Introduction
Macular regeneration is a majorly age-associated retinal condition that leads to central vision loss. It affects an individual’s macula, that is, the central part of the retina. The retina is present in the back of the eye and is responsible for controlling the central vision. The peripheral vision remains fine. It might affect one or both eyes with a distinct severity level. The current treatment regimen for macular regeneration focuses on addressing symptoms, but there is no cure. Stem Cells for Macular Degeneration address the root cause of the problem by facilitating macular regeneration.
What is Age-Related Macular Degeneration?
Macular degeneration affects an individual’s ability to see things that are directly in front of them. With increased age, the term ‘age-related macular degeneration’ (AMD) implies. This means that as individuals get older, they are affected by the degeneration of the macula. There are mainly two types of AMD, including:
- Dry AMD: Known as atrophic degeneration, where an individual develops tiny yellow spots called drusen under the macula. Approximately 90% of the cases are dry AMD. The dried layer leads to macular thinning.
- Wet AMD: Known as exudative degeneration that occurs due to the development of abnormal blood vessels under the retina and macula. Blood leaks from blood vessels, fluid builds up that forms bulges in the macula.
The major causes and symptoms of macular degeneration include:
- Genetic predisposition
- Diabetes
- Infections
- Head injuries
- Nutritional deficiencies
Symptoms of macular degeneration include:
- Blurred vision
- Inability to see in low light
- Problem in seeing colours
- Straight lines appearing curvy or wavy
- Black sport in the field of vision
Current Macular Degeneration Treatment Options
Currently, macular degeneration treatment in India includes:
- Nutritional supplementation (AREDS/ARED2) (Vitamin C, E, Letein, Copper, Zinc), prescribed in case of dry AMD
- Anti-VEGF injections (in case of wet AMD)
- Laser photocoagulation, for wet MD, involves the use of a laser to seal or destroy the leaky vessels.
Stem Cell Therapy in Macular Degeneration
Conventional macular degeneration treatment in India is subjected to various challenges. Researchers and clinicians have focused on a regenerative approach using stem cells for macular degeneration. The use of mesenchymal stem cells (MSCs) has shown potential in macular regeneration.
The mechanism of action includes:
- Tissue Regeneration: MSCs have properties for macular regeneration that aid in the development of new cells and replace the dead or damaged macula
- Neuroprotection: Stem cells release various growth factors, neurotrophic factors, and cytokines that enable neuroprotection. The existing surrounding cells or macula encounters a supportive environment.
- Anti-Inflammatory Effects: Stem cells release various anti-inflammatory cytokines, reducing inflammation surrounding the macula, one of the major contributors in macular degeneration.
How Stem Cell Treatment Works for Macular Degeneration?
Stem cells for macular degeneration have multifold benefits, including:
- Restoration of damaged retinal pigment epithelium
- Support to photoreceptor cells, induces a repair mechanism and creates a healthier retinal microenvironment
- Reduction of retinal inflammation or swelling
- Potential for vision stabilization or improvement
The research in Stem Cell Treatment for Macular Degeneration in India is growing due to its potential regenerative application.
Stem Cell Treatment for Macular Degeneration in India
India is considered a popular hub for medical tourism due to the presence of world-class infrastructure, experienced clinicians, facilitating quality treatment, and comprehensive pricing. The main factors supporting development include:
- Growth of regenerative medicine centers
- Availability of advanced stem cell facilities
- Regulatory considerations and ethical practices
- Availability of supportive infrastructure, experienced clinicians, aftercare and rehabilitation after the treatment
What are the Benefits and Potential Risks?
The benefits of stem cell for macular degeneration include:
- Minimally invasive procedure
- Potentially slow macular degeneration
- Improved retinal microenvironment
- Anti-inflammation around the retina and its walls
- Prevention of leaky vessels by replacement of damaged retinal pigment epithelium cells
Preclinical and clinical trials have marked the therapy as safe; however, the potential risk includes:
- Variability in patient’s response
- Use of quality stem cells, variation in cell sourcing, isolation and culture conditions
- Need for long-term clinical supervision
- Lack of long-term safety evidence based on large-scale clinical trials
- Importance of choosing certified centers
Who is an Ideal Candidate?
Patient’s selection is an important criterion in the application of stem cells for macular degeneration:
- Individuals at the early to moderate stage of AMD patients
- Patients unresponsive to conventional treatment
- Detailed ophthalmological evaluation and other health conditions of the patient to ensure suitability
Conclusion
Stem cell therapy is a promising advancement in managing Age-Related Macular Degeneration. It focuses on retinal repair, neuroprotection, and macular regeneration. Besides, stem cell–based approaches aim to address the underlying cellular damage. With the emergence of new technology, clinicians must ensure informed-decision making for the patient. In the future, large-scale safety data must be compiled through long-term clinical trials. Thus, professional guidance along with comprehensive research findings and consideration helps patients and clinicians make safe, evidence-based choices while exploring innovative options that may protect and preserve vision for the future.
